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Abstract. 
 
Gab1 is a substrate of the receptor tyrosine 
kinase c-Met and involved in c-Met–specific branching 
morphogenesis. It associates directly with c-Met via the 
c-Met–binding domain, which is not related to known 
phosphotyrosine-binding domains. In addition, Gab1 is 
engaged in a constitutive complex with the adaptor pro-
tein Grb2. We have now mapped the c-Met and Grb2 
interaction sites using reverse yeast two-hybrid technol-
ogy. The c-Met–binding site is localized to a 13–amino 
acid region unique to Gab1. Insertion of this site into 
the Gab1-related protein p97/Gab2 was sufficient to 
confer c-Met–binding activity. Association with Grb2 
was mapped to two sites: a classical SH3-binding site 
(PXXP) and a novel Grb2 SH3 consensus-binding mo-
tif (PX(V/I)(D/N)RXXKP). To detect phosphoryla-
tion-dependent interactions of Gab1 with downstream 
substrates, we developed a modified yeast two-hybrid 
assay and identified PI(3)K, Shc, Shp2, and CRKL as 
interaction partners of Gab1. In a trk-met-Gab1–spe-
cific branching morphogenesis assay, association of 
Gab1 with Shp2, but not PI(3)K, CRKL, or Shc was es-
sential to induce a biological response in MDCK cells. 
Overexpression of a Gab1 mutant deficient in Shp2 in-
teraction could also block HGF/SF-induced activation 
of the MAPK pathway, suggesting that Shp2 is critical 
for c-Met/Gab1-specific signaling.
Key words: Gab1 • c-Met–binding site • morphogen-
esis • Shp2 • reverse yeast two-hybrid analysis
 
Introduction
 
Gab1, like the insulin receptor substrates (IRS)
 
1
 
, the FGF
receptor substrate FRS-2/SNT1, and p62dok (downstream
of kinases) family members, belongs to a newly identified
group of docking proteins that function as specific sub-
strates of tyrosine kinases (Sun et al., 1991, 1995; Holgado-
Madruga et al., 1996; Weidner et al., 1996; Kouhara et al.,
1997; Carpino et al., 1997; Yamanashi and Baltimore,
1997; Di Cristofano et al., 1998; reviewed by Pawson and
 
Scott, 1997). These proteins are characterized by a
 
NH
 
2
 
-terminal lipid-binding domain, like PH domain or
NH
 
2
 
-terminal myristylation sequence, which mediate
membrane targeting, and a central PTB-like domain that
directs association with specific tyrosine kinases (Eck et
al., 1996; Jones and Dumont, 1998, 1999; Nelms et al.,
1998; Meakin et al., 1999; Xu et al., 1999). In addition, they
contain multiple tyrosine residues that upon phosphoryla-
tion function as docking sites for SH2 domain containing
signaling molecules.
 
Gab1 is a substrate of the receptor tyrosine kinase
c-Met and involved in c-Met–specific cell dissociation and
branching morphogenesis (Weidner et al., 1996; Maroun
et al., 1999). It contains a NH
 
2
 
-terminal PH domain, but
lacks a classical PTB domain (Holgado-Madruga et al.,
1996). Instead, it contains a novel phosphotyrosine rec-
ognition domain, initially called c-Met–binding domain,
MBD, which mediates direct association with the c-Met
receptor (Weidner et al., 1996). Gab1 binds to two sites of
the cytoplasmic tail of c-Met, Y14 (Y1349) and to a lesser
extent, Y15 (Y1356) (Weidner et al., 1996; Nguyen et al.,
1997; Bardelli et al., 1997). Y14 and Y15 constitute the so-
called bivalent docking site of c-Met and associate with
 
many signaling molecules besides Gab1, like PI(3)K, PLC-
 
g
 
,
pp60 c-Src and Shc (Ponzetto et al., 1994; Pelicci et al.,
1995; Fixman et al., 1995). In addition, Y15 can associate
with Grb2 (Ponzetto et al., 1994). Mutation of the Grb2
consensus binding site in c-Met impairs association with
Grb2 and also with Gab1 (Nguyen et al., 1997; Bardelli et
al., 1997). Gab1 forms a constitutive complex with Grb2.
This interaction is mediated primarily via the COOH-ter-
minal SH3 domain of Grb2 (Holgado-Madruga et al.,
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Abbreviations used in this paper: 
 
CSW, Corkscrew; DOS, daughter of
Sevenless; Gab1, Grb2-associated binder 1; HA, hemagglutinin; IRS, insu-
lin receptor substrates; MBS, c-Met–binding site; PI(3)K, phosphatidyl-
 
inositol 3-kinase; PLC-
 
g
 
, phospholipase C-
 
g
 
; SH, Src homology.
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1996; Nguyen et al., 1997; Fixman et al., 1997), leaving the
SH2 domain free to bind activated c-Met. Thus, coupling
by Grb2 may provide an alternative mechanism for re-
cruitment of Gab1.
Genetic experiments in mice have shown that the multi-
ple docking site is essential for c-Met function: mice ex-
pressing c-Met mutants in which both tyrosines of the mul-
tiple docking site are mutated to phenylalanine have a
 
phenotype comparable to c-Met
 
2/2
 
 
 
mice (Bladt et al., 1995;
Maina et al., 1996). These mice die around embryonic day
14 and are characterized by placenta and liver defects and
retardation of muscle precursor cell migration to the
limbs. Mice that carry mutations in the Grb2-binding site
(Y1356VNV to 1356VHV) of c-Met develop to term but
also show muscle defects. Similarly, it was shown by in
vitro experiments that Y14 and Y15 of c-Met are required
for c-Met–specific branching morphogenesis of MDCK
cells (Zhu et al., 1994; Weidner et al., 1995; Sachs et al.,
1996).
In addition, Gab1 is involved in other signaling path-
ways. Gab1 overexpression enhances the transforming and
growth promoting activities of activated EGF and insulin
receptors and promotes NGF-stimulated survival of neu-
ronal cells (Holgado-Madruga et al., 1996, 1997). Many ex-
tracellular stimuli like EGF, insulin, IL3, IL6, erythropoi-
etin (Epo), as well as B cell receptor activation induce
Gab1 phosphorylation and association with Shc, PI(3)K,
 
PLC-
 
g
 
, Ship, and Shp2 (Holgado-Madruga et al., 1996;
Takahashi-Tezuka et al., 1998; Lecoq-Lafon et al., 1999;
Ingham et al., 1998; Rodrigues et al., 2000). Association of
Gab1 with PI(3)K has been shown to be important for pre-
vention of apoptosis in response to NGF stimulation (Hol-
gado-Madruga et al., 1997). A Gab1 homologue, DOS
(daughter of sevenless), has been identified in 
 
Drosophila
 
(Herbst et al., 1996; Raabe et al., 1996). DOS interacts
with the Shp2 homologue Corkscrew (CSW) and together
with CSW is involved in signaling by the receptor tyrosine
kinases Sevenless, Torso, and the 
 
Drosophila
 
 EGF recep-
tor (DER). Genetically, DOS has been mapped down-
stream of Sevenless and upstream of Ras (Herbst et al.,
1996; Raabe et al., 1996).
 
Here we have analyzed the interactions of Gab1 with
c-Met, Grb2, and downstream signaling components. We
show that a 13–amino acid c-Met–binding site, now called
MBS, mediates direct association of Gab1 with c-Met. Ty-
rosine phosphorylation induces interaction of Gab1 with
PI(3)K, Shc, Shp2 and CRKL. The Shp2-binding site is es-
sential for c-Met–induced branching morphogenesis activ-
ity and for activation of the MAPK pathway, implicating
Shp2 as an important effector for c-Met/Gab1 signaling.
 
Materials and Methods
 
Plasmid Construction
 
Gab1 cDNAs encoding residues 416–570 of Gab1 were generated by PCR
and inserted into the prey vectors VP16 (Weidner et al., 1996) and pPC86-
Cyh (Vidal et al., 1996b). Similarly, full-size cDNA of Grb2 was subcloned
into the bait vectors pCF87-Cyh2 and BTM116 (Weidner et al., 1996) us-
ing Sal1 and Sma1 or EcoR1 and Sal1 sites, respectively. The cytoplasmic
domain of c-Met was subcloned into the bait vector pCF87-Cyh2 by a sim-
ilar strategy (Chevray and Nathans, 1992). The bait vectors BTM-c-Met
and BTM-c-MetK- have been described (Weidner et al., 1996). Gab1 mu-
tations identified in the two-hybrid screens were inserted into full-size
Gab1 cDNAs (pBat-FlagGab1 or VP16-Gab1, Weidner et al., 1996) tak-
ing advantage of internal Bgl2 sites of Gab1 cDNA. Additional point mu-
tations or small deletions (
 
D
 
341-348) were introduced into the Gab1
cDNA by site-directed mutagenesis using a commercial kit (CLONTECH
Laboratories, Inc.) or by PCR using oligonucleotide primers containing
respective base substitutions. The Gab1 mutant 
 
D
 
CBR was constructed in
two steps: A DNA fragment (Not1-Sal1) encoding residues 411–695 of
Gab1 was inserted into the pBatFlag and VP16 vector. NH
 
2
 
-terminal cod-
ing sequences, residues 1–241 or 116–241 (
 
D
 
PH) were subsequently in-
serted into the Not1 sites of these constructs. BTM-tpr-met-control (lack-
ing the multiple docking site of Met) was constructed by inserting a PCR
fragment encoding residues 1–479 of tpr-met plus a nested Not1 site into
the EcoR1 site of BTM116 (Weidner et al., 1996). Wild-type and mutant
Gab1 cDNA fragments were inserted into the Not1 and Sal1 sites of
BTM-tpr-met-control, generating various BTM-tpr-met-Gab1 bait vec-
tors. pcDNA-trk-met-Gab1 expression vectors were constructed similarly:
trk-met cDNA (Sachs et al., 1996) encoding the extracellular domain of
trk and only the kinase domain of c-Met plus an internal Not1 site was in-
serted into Xho1 and EcoR1 sites of pcDNA3.1mycB vector (Invitrogen).
Gab1 cDNA fragments were then subcloned into Not1 and Kpn1 sites of
pcDNAtrk-met-control in frame with the myc epitope-tag at its 3
 
9
 
 end.
P97/Gab2 cDNA was obtained from H. Gu and B.G. Neel (Harvard Med-
ical School, Boston, MA) and inserted into the pBatFlag expression vec-
tor. P97
 
1
 
MBS was generated by overlapping PCR (Sachs et al., 1996) us-
ing a combination of internal primers encoding the MBS of Gab1 (see Fig.
2 A) and external primers specific for p97/Gab2.
 
Random Mutagenesis and Reverse Two-Hybrid Screens
 
Random mutagenesis of Gab1 cDNAs was carried out by PCR using Taq
 
polymererase in the presence of 50, 100, or 200 
 
m
 
M Mn
 
2
 
1
 
, 50 
 
m
 
M dNTP,
and pPC-Gab416-570 or VP16-Gab416-570 as template. PCR products
were incorporated into appropriate prey vectors by gap repair in yeast
(Mulhard et al., 1992). Mutations that dissociate interactions with c-Met
were identified by reverse two-hybrid analysis (Vidal et al., 1996a). In
brief, the yeast strain MaV103a was cotransformed with pCF87-c-Met, the
PCR products and linearized pPC86 plasmid vector for recombination.
Transformants were selected against c-Met binding by replica plating on
selective plates containing 0.2% (wt/vol) fluoroorotic acid (FOA). Yeast
clones expressing noninteracting cDNA clones were isolated and mated
with MAV103
 
a
 
 strain transformed with pCF87-Grb2. Cell clones were se-
lected for positive interaction with Grb2 by growth on minimal plates
 
lacking histidine in the presence of 50 mM 3-amino-1, 2, 4, triazole
(3-AT). cDNAs were recovered (Ling et al., 1995) and the phenotype
confirmed by retransformation of yeast with c-Met and Grb2 baits. Gab1
mutants defective for Grb2 interaction were identified by blue-white color
screening (Li and Fields, 1993) using the yeast strain L40 (Weidner et al.,
1996) transformed with BTM-Grb2. After cotransformation of the Gab1
mutant cDNA plus linearized VP16 prey vector (Weidner et al., 1996),
 
yeast colonies were replica-plated onto selective plates containing 80
 
m
 
g/ml 5-bromo-4-chloro-3-indolyl-
 
b
 
-
 
D
 
-galactopyranoside (X-gal). Gab1
cDNAs were recovered from white yeast colonies and subsequently tested
for yeast two-hybrid interaction with BTM-c-Met. Interactions were quan-
tified by 
 
b
 
-galactosidase liquid assay using 
 
O
 
-nitrophenyl 
 
b
 
-
 
D
 
-galactopy-
ranoside (ONPG) as a substrate (Chien et al., 1991).
 
Antibodies, Immunoprecipitation, Western Blotting
 
Anti-Gab1 serum was raised against residues 391–532 of Gab1 and affinity
purified. Antibodies against c-Met and CRKL were purchased from Santa
Cruz Biotechnology Inc., anti-p85 PI(3)K, anti-Crk, anti-Shp2, and anti-
phosphotyrosine antibodies were obtained from Transduction Laborato-
 
ries, and anti-HA antibodies were purchased from Boehringer. Anti-
active MAPK serum (pErk) was obtained from Promega. 293 cells were
seeded at 1 
 
3
 
 10
 
6
 
 cells per 10-cm dish and transfected the following day by
standard Ca/PO4 precipitation method (Ausubel et al., 1992). 2 d post-
 
transfection, cells were starved in serum-free medium for 1 h and with 50 U
recombinant HGF/SF (Weidner et al., 1993) in the presence of 10 mM
phenyl-arsenine-oxide. After washing with PBS, proteins were solubilized
in lysis buffer (150 mM NaCl, 1 mM EDTA, 50 mM Hepes, pH 7.5, 1%
Triton X-100, 10% glycerol) supplemented with 100 mM NaF, 1 mM so-
dium orthovanadate, sodium pyrophosphate, and 1 mM PMSF. Proteins
were precipitated with anti-Flag affinitiy agarose gel (Sigma-Aldrich), re-
solved by SDS-PAGE, and transferred to nitrocellulose membranes.
Membranes were blocked for 1 h with 5% dry milk in PBS containing
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0.1% Tween 20 (PBST) or 10% FCS in PBST (for anti-phosphotyrosine
detection) followed by incubation with primary antibody diluted in block-
ing buffer. After washing in PBST, blots were incubated with horseradish
peroxidase conjugated anti-mouse secondary antibody (Jackson Immu-
noResearch Laboratories) or anti-rabbit secondary antibody (Calbio-
chem-Novabiochem) and developed with a chemiluminescent detection
system (Amersham Pharmacia Biotech).
 
Branching Morphogenesis Assay
 
MDCK cells were transfected with trk-met-Gab1 expression plasmids and
selected for neomycin resistance in the presence of 800 
 
m
 
g/ml G418. Indi-
vidual cell clones were expanded and seeded in collagen matrix containing
DME and 10% FCS, as previously described (Sachs et al., 1996). Branch-
ing morphogenesis was induced by addition of NGF (100 ng/ml) or HGF/
SF (50 U/ml) every 2 d. After 5–7 d of culture, cells were fixed with 0.1%
glutaraldehyde in PBS and photographed using a light microscope with in-
terference optic.
 
Elk1 Transactivation Reporter Assay
 
293 cells seeded in 6-well dishes were transfected with pBat-Flag-Gab1 ex-
pression plasmids, pFA2-Elk1, pFR-Luc (Stratagene) and pSV40 LacZ
expression vector. 2 d after transfection, cells were stimulated with HGF/
SF (50 U/ml) for 5 h. Cells were resuspended in PBS and lysed by three
freeze and thaw cycles. The extract was analyzed for 
 
b
 
-galactosidase and
luciferase activity using ONPG and luciferin as suggested by the manufac-
turer of the kit (Stratagene).
 
Results
 
Gab1 Contains Separate Binding Sites for c-Met
and Grb2
 
We and others have previously shown that Gab1 can asso-
ciate directly with the c-Met receptor tyrosine kinase
(Weidner et al., 1996; Bardelli et al., 1997; Nguyen et al.,
1997). By deletion analysis, we had located the MBD of
Gab1 to an 83–amino acid region in the central region of
Gab1, residues 450–532. This interaction is dependent on
c-Met phosphorylation. However, significant sequence ho-
mology of the MBD to other known phosphotyrosine-
binding modules was not detected. In addition to c-Met
association, we found that the MBD of Gab1 is also suffi-
cient to interact with Grb2 (see also Holgado-Madruga et
al., 1996).
To define the c-Met–binding site of Gab1 and to sepa-
rate the c-Met from Grb2–binding function, we carried out
a Gab1 mutant screen by reverse yeast two-hybrid analysis
(Vidal et al., 1996a). Gab1 cDNA encoding the initially
defined c-Met–binding domain plus adjacent amino acids,
position 416–570, was mutated randomly via PCR and
tested for two-hybrid interactions with c-Met and Grb2.
cDNA clones that displayed reduced interaction with c-Met
but not Grb2, and vice versa, were selected and analyzed
for mutations in the Gab1 coding region. 17 single point
mutants with reduced binding properties to c-Met and 4
point mutations with reduced Grb2 association were iden-
tified by this method (Fig. 1 A). Additional mutations in
this region were generated by site-directed mutagenesis
and also included in the analyses (depicted in italics in Fig.
1). Altogether we identified 18 point mutations that inter-
fered with c-Met binding. All of these were localized in a
13–amino acid region, amino acids 487–499, marked black
in Fig. 1 A. In contrast, all of the 7 point mutations that in-
terfered with Grb2 association mapped to a different re-
gion, amino acids 518–526, marked in gray. All mutants
represented in Fig. 1 displayed reduced interaction, 
 
,
 
10%,
 
with one binding partner, while association with the other
binding partner was little affected, with at least 80% inter-
action remaining. Therefore, we presume that these muta-
tions do not or only locally disturb the structural integrity
of Gab1. Rather the different locations of these mutations
reveal direct contact sites for protein–protein interactions,
the c-Met–binding site, now called the MBS, at residues
487–499, and the Grb2-binding site, GBS1, at residues
518–526.
The c-Met–binding site of Gab1 appears to be unique,
since we did not detect homologous sequences in the gene
bank data base using Blast analysis programs (Altschul et
al., 1990). The GBS1 constitutes a novel Grb2 interaction
motif, since it lacks the PXXP sequence which is found in
most known Grb2 SH3 and other SH3 domain–binding
sites (Feng et al., 1994). A Blast search of the GBS1
peptide identified homologous sequences in the Gab1-
related proteins p97/Gab2, 
 
Drosophila
 
 DOS and 
 
C
 
.
 
 ele-
gans
 
 F41F3.2 as well as in the T and B cell linker proteins
SLP-76 and BLNK (Fig. 1 B). The latter two are known to
interact with Grb2 (Jackman et al., 1995; Fu et al., 1998).
The Grb2-binding site of SLP-76 has been mapped to a
20–amino acid region, amino acids 224–244 (Motto et al.,
1996), which encompasses a peptide sequence homologous
to the GBS1 of Gab1 (Fig. 1 B). When we exchanged the
GBS1 of Gab1, PPVDRNLKP, with the corresponding se-
quence of SLP-76, PSIDRSTKP, we found that this hybrid
construct bound Grb2 with similar strength compared with
native Gab1 fragment (data not shown), suggesting that
the SLP-76 derived peptide can also function as Grb2-
binding site. From the alignment of GBS1 homologous se-
quences and the results of the Gab1 mutant analyses (Fig.
1, A and B), the following novel Grb2 consensus-binding
sequence can be deduced, PX(V/I)(D/N)RXXKP.
Previous mutant analyses were carried out with Gab1
cDNA encoding residues 416–570 of Gab1. To assess, if
Gab1 contains additional binding sites for c-Met or Grb2
outside this region, we introduced the mutations of the
MBS (V490A) or GBS1(L524P) into the full-size cDNA
of Gab1 (Fig. 1 C). Similar to the shorter Gab1 fragment
used in the screen, c-Met binding of the full-size Gab1
mutant V490A (
 
D
 
c-Met) was reduced to 
 
,
 
5% compared
with wild-type Gab1 (Fig. 1 C). This association requires
c-Met phosphorylation, since no significant association with
kinase-inactive c-Met mutant was detected (c-MetK-, Fig.
1 C;  Weidner et al., 1996). However, the GBS1 mutation
L524P had only a moderate effect on the interaction of
full-size Gab1 with Grb2, 
 
z
 
50% reduction. A proline-rich
sequence PPPRPPKP, residues 341–348, is located NH
 
2
 
-
terminally and resembles the Grb2-binding sites of Sos
(GBS2 in Fig. 1 B; Feng et al., 1994). Deletion of this
sequence in addition to the L524P mutation (
 
D
 
Grb2)
abrogates association with Grb2, while interaction with
c-Met is little affected (Fig. 1 C). These results demon-
strate that Gab1 contains two Grb2-binding sites: a novel
binding site, the GBS1, and a classical SH3-binding site,
the GBS2. Both sites do not overlap with the c-Met–bind-
ing site, MBS.
 
In Vivo Interaction of Gab1 with c-Met and Grb2
 
Direct interaction of Gab1 with c-Met requires Y14
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(Y1349) of c-Met (Weidner et al., 1996). Y15 (Y1356) has
also been shown to be important for association of c-Met
with Gab1 (Weidner et al., 1996; Bardelli et al., 1997;
Nguyen et al., 1997). Since Grb2 can bind to Y15 of c-Met
via its SH2 domain and to Gab1 via its SH3 domains (Hol-
gado-Madruga et al., 1996; Fixman et al., 1997), Grb2
could stabilize the Gab1-c-Met interaction in vivo by
forming a triple complex with c-Met and Gab1. To assess
the contribution of Grb2 for Gab1-c-Met association in
cells, we carried out immunoprecipitation analyses using
the newly identified mutants: 293 human kidney epithelial
 
cells were transfected with plasmid vectors expressing Flag
epitope-tagged Gab1 proteins and HA epitope-tagged
Grb2. After stimulation of endogenous c-Met with HGF/
SF, Gab1 and its mutant proteins were precipitated with
anti-Flag antibodies and immune complexes analyzed by
Western blotting (Fig. 1 D). Interaction of Gab1 with
c-Met is abrogated by the MBS mutation (
 
D
 
c-Met), while
the Gab1 mutant which lacks both Grb2 association sites
(
 
D
 
Grb2) can still bind c-Met, even though at a reduced
strength compared with wild-type Gab1. Grb2 association
with Gab1 was not affected by the V490A mutation in the
Figure 1. Identification of c-Met and Grb2-binding sites of Gab1
by yeast two-hybrid analysis. (A) Reverse two-hybrid screens
with Gab1 fragments encoding residues 416–570 of Gab1 (see
bar). Gab1 cDNA was mutated by PCR and selected against in-
teractions with c-Met or Grb2. Displayed are single point muta-
tions, that interfered with the association of one binding partner
(,10% interaction), but not the other (at least 80% interaction
remaining). The mutations displayed in italics were generated by
site-directed mutagenesis. Mutations interfering with c-Met asso-
ciation are localized in the MBS, residues 487–499, marked in
black, mutations interfering with Grb2 association are localized
in the GBS1, residues 518–526, marked in grey. (B) The GBS1 of
Gab1 constitutes a novel Grb2-binding site. Similar sequences
are found in the Grb2-binding adaptor proteins p97/Gab2, SLP-
76 and BLNK. Drosophila DOS contains two of these putative
Grb2-binding sites. F41F3.2 encodes a hypothetical protein from
C. elegans (Wilson et al., 1994). In the alignment, ! can be V or I,
and # can be D or N. A second Grb2-binding site (GBS2) is
present in Gab1 and p97/Gab2 sequence. Shown below is an
alignment of the GBS2 with Grb2-binding peptides derived from
Sos. The PXXPXR consensus binding site is found in various
SH3 domain binding peptides (Feng et al., 1994). (C) Yeast two-hybrid interactions of full-size Gab1 prey vectors with c-Met, the ki-
nase-inactive c-Met mutant, c-MetK-, or Grb2 as bait. Interactions of mutant Gab1 proteins are displayed as a percentage of wild-
type Gab1-c-Met or Gab1-Grb2 association. *Associations with c-MetK- are displayed as percentage of Gab1-c-Met interaction. The
proline-rich sequence PPPRPPKP (GBS2) is deleted by the D341-348 mutation. (D) Association of Gab1 mutants with c-Met and Grb2
in tissue culture. 293 cells were transfected with HA-tagged Grb2 expression vector plus pBat-Flag (Control) or expression vectors en-
coding Flag-tagged Gab1 proteins as indicated. After stimulation with HGF/SF, proteins were precipitated with anti-Flag agarose. Pro-
teins were separated by SDS-PAGE and probed with antibodies as indicated.
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MBS (
 
D
 
c-Met), but impaired by mutation of the two
Grb2-binding sites (
 
D
 
Grb2). These results demonstrate
that in cells association of Gab1 with c-Met depends on di-
rect interaction via its MBS, while Grb2 binding may add
to the strength of the interaction.
 
The c-Met–binding Site of Gab1 Confers c-Met 
Association to p97/Gab2
 
Recently, p97/Gab2 was identified as a docking protein
that is most closely related to Gab1 (Gu et al., 1998;
Nishida et al.,
 
 
 
1999; Zhao et al., 1999). The amino acid se-
quence displays 73% identity in the PH domain and 37%
overall similarity with Gab1. The Grb2-binding sites (Fig. 1
B) as well as consensus binding sites for PI(3)K, Shp2, and
Crk are conserved, but sequences homologous to the MBS
of Gab1 are not present in p97/Gab2 (Fig. 2 A). Yeast
two-hybrid analyses confirmed that p97/Gab2 binds Grb2,
even though somewhat weaker than Gab1, but it does not
directly associate with c-Met (data not shown). To test, if
the MBS of Gab1 was responsible for mediating c-Met
binding, we inserted the MBS of Gab1 plus flanking se-
quences, residues 484–499, into the corresponding region
of p97/Gab2 cDNA (Fig. 2 A) and expressed this hy-
brid protein in 293 cells. Wild-type p97/Gab2 prepared
from HGF/SF activated cell extract did not associate with
c-Met, but the p97 hybrid containing the MBS of Gab1 did
(Fig. 2 B). This shows that the MBS of Gab1 is necessary
and that it mediates the interaction with c-Met. Grb2
could also be detected in p97/Gab2 precipitatations, but
the interaction with p97/Gab2 is weaker than with Gab1 or
the p97/Gab1 hybrid.
 
Interaction of Gab1 with Downstream
Signaling Molecules
 
Gab1 has the structure of a docking protein and contains
21 tyrosine residues that upon phosphorylation could
function as docking sites for signaling molecules (Hol-
gado-Madruga et al., 1996; Weidner et al., 1996). Stimula-
tion with growth factors like HGF/SF, EGF, insulin, or
interleukins IL3, IL6, and Epo induces tyrosine phosphor-
ylation of Gab1 and association with PI(3)K, PLC-
 
g
 
, Shc
and Shp2 (Holgado-Madruga et al., 1996; Weidner et al.,
1996; Takahashi-Tezuka et al., 1998; Lecoq-Lafon et al.,
1999).
To map the interaction sites of known Gab1-binding
partners and to identify potential new interaction partners
of Gab1, we developed a modified yeast two-hybrid assay
that detects phosphorylation-dependent interactions of ki-
nase substrates (Fig. 3 A). Tpr-met is an oncogenic deriva-
tive of c-Met and encodes the kinase domain of c-Met in
frame with a leucin-zipper dimerization domain derived
from a different gene locus (Park et al., 1986). Because of
its acquired dimerization domain, tpr-met is constitutively
active in mammalian cells as well as in yeast (Rodrigues
and Park, 1993, and data not shown). While substrates are
usually recruited through binding to the multiple docking
site of c-Met, we found that Gab1 fused COOH-terminally
to the kinase domain of tpr-met, which lacks the multiple
docking site, is also efficiently phosphorylated (data not
shown). Thus, a bait vector expressing LexA DNA bind-
ing and dimerization domain in frame with a tpr-met-Gab1
cDNA interacts with SH2 domains of PI(3)K, PLC-
 
g
 
, and
Shc (Fig. 3 A). These interactions were specific for Gab1,
since the kinase domain of tpr-met lacking the multiple
docking site is largely insufficient to mediate the interac-
tions. The tpr-met-Gab1 fusion protein was then used as a
bait for extensive yeast two-hybrid screening of a mouse
E10 expression library (Weidner et al., 1996). By this
method, we isolated several cDNA clones encoding the
COOH-terminal SH2 domain of p85
 
a
 
 or p85
 
b
 
 PI(3)K and,
as newly identified partners, cDNA clones encoding SH2
domains of the adaptor proteins Crk and CRKL (Fig. 3 A,
and data not shown). Previously identified Gab1-binding
proteins, PI(3)K, PLC-
 
g
 
, Shp2, and Shc, associate also di-
rectly with c-Met (Ponzetto et al., 1994; Pelicci et al., 1995;
Fixman et al., 1996). CRKL does not bind c-Met directly,
but can be recruited specifically by Gab1 (Fig. 3 A).
Figure 2. Insertion of the c-Met–binding site confers c-Met asso-
ciation to p97/Gab2. (A) Alignment of the central regions of
Gab1 and p97/Gab2. Underlined are the sequences that define
the c-Met–binding site (MBS) or the Grb2-binding site (GBS1)
of Gab1. Shown below is the insertion of MBS coding sequences
into p97/Gab2 cDNA. Gab1-derived sequences of the p971MBS
hybrid are displayed in bold. (B) p97/Gab21MBS associates with
c-Met in cultured cells. 293 cells were transfected with HA-Grb2
and Flag-tagged Gab1 expression vectors and were stimulated
with HGF/SF. After immunoprecipitation with anti-Flag agarose,
proteins were detected by Western blotting with anti–c-Met, anti-
HA and anti-Flag antibodies as indicated.
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Interactions of Gab1 with Substrates Are 
Phosphorylation Dependent
 
To confirm that the interactions of Gab1 with the sub-
strates, including CRKL, were dependent on Gab1 phos-
phorylation, we examined these interactions in mamma-
lian cells after HGF/SF stimulation. Flag epitope-tagged
Gab1 was precipitated from transiently transfected 293
cells and detected by Western blotting using an anti-phos-
photyrosine monoclonal antibody (Fig. 3 B). In the ab-
sence of HGF/SF, a basal level of Gab1 phosphorylation
was detected, but the level increased to a maximum of
about fourfold after 5–10 min of HGF/SF stimulation.
Concomitant with the increase in Gab1 phosphorylation,
binding of CRKL, Shp2, and the p85 subunit of PI(3)K
was enhanced, suggesting that these interactions are phos-
phorylation dependent. Even though Crk and CRKL were
both found in the screen, only CRKL immunoprecipitated
efficiently with Gab1. Therefore, it appears that from the
Crk family of proteins, CRKL is the major association
partner of Gab1.
 
Binding Sites of Gab1 to Various Interaction Partners
 
The binding sites of Gab1 interacting molecules were
 
mapped by yeast two-hybrid as well as biochemical anal-
yses, using a combination of deletion and point mutants.
In the yeast two-hybrid assay, deletion of the PH domain
(
 
D
 
PH) slightly enhanced the binding activity of Gab1 with
several partners. Therefore, we introduced subsequent
mutations into the 
 
D
 
PH background (Fig. 4 A). Six con-
sensus binding sites for Crk/CRKL (YXXP) are clustered
between residues 242–410, the CRKL-binding region (CBR)
of Gab1 (Songyang et al., 1993; Sakkab et al., 2000). Bind-
ing of CRKL was not significantly reduced by mutations of
individual tyrosine residues of the CBR (data not shown),
but deletion of the NH
 
2
 
 terminus of Gab1, residues 1–449
(Gab1Cter) or just the CBR, amino acids 242–410 (
 
D
 
CBR),
diminished interaction with CRKL, suggesting that all
CRKL-binding sites are located in the CBR. The Shc in-
teraction site was also localized to the NH
 
2
 
-terminal part
of Gab1, but it maps outside the CRKL-binding region,
since Shc could still bind to the Gab1 mutant 
 
D
 
CBR which
lacks this region. Shp2 interacts with the consensus bind-
ing site at Y628 in the COOH-terminal part of Gab1, since
mutation of Y628 to phenylalanine (
 
D
 
Shp2) blocks associ-
ation with Shp2 (Fig. 4 A; Rocchi et al., 1998). The interac-
tion of Shp2 with the Gab1Cter construct was about
fivefold stronger than with Gab1
 
D
 
PH. In yeast, tyrosine
Figure 3. Phosphorylation-dependent interaction of Gab1 with
substrates. (A) Modified yeast two-hybrid assay. Interaction of
Gab1 with substrates is induced by fusion with LexA-tpr-met ki-
nase. Tpr-met bait vectors lack the multiple docking site of Met,
and efficient interaction with substrates is dependent on Gab1
cDNA. Prey vectors encode the SH2 domain of p85a PI(3)K
(SH2-2), CRKL, PLC-g, or full-size cDNAs of Shc and Shp2. The
CRKL cDNA clone was identified in a screen for Gab1 interact-
ing cDNAs. It does not associate with c-Met. 111 . 100 , 11 .
50, 1 . 25 b-galactosidase units. (B) HGF/SF enhances Gab1
phosphorylation and association with signaling molecules. 293
cells were transfected with expression vectors encoding Flag-
tagged Gab1 and p85a PI(3)K. After serum starvation for 1 h,
cells were stimulated with 50 U/ml HGF/SF for the time period
indicated. Proteins were precipitated with anti-Flag beads and
detected by Western blotting.
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phosphorylation of tpr-met-Gab1Cter is much stronger
than of the longer baits, tpr-met-Gab1 or tpr-met-Gab1
 
D
 
PH (data not shown). Therefore, it is likely, that the en-
hanced Shp2 association by Gab1Cter bait is due to more
efficient phosphorylation of the Shp2-binding site of this
construct. Similarly, p85 PI(3)K interacts stronger with
Gab1Cter than with the longer Gab1
 
D
 
PH construct.
Gab1 contains three consensus binding sites for PI(3)K: at
Y448, Y473 and Y590 (Holgado-Madruga et al., 1997).
Mutation of all three tyrosines to phenylalanine in Gab1
 
D
 
PH (
 
D
 
PI(3)K) reduces yeast two-hybrid interaction by
only 
 
z
 
50%. Thus additional binding sites for PI(3)K must
exist. Mutation of the PI(3)K consensus binding sites in
Gab1Cter reduced the interaction to 
 
z
 
25% compared
with Gab1Cter (Fig. 4 A). Similar results were obtained
when interactions were analyzed in mammalian expres-
sion systems: Gab1 mutant proteins were transiently ex-
pressed in 293 cells and precipitated after stimulation with
HGF/SF. Western blots were probed sequentially with
antibodies against CRKL, p85, Shp2, and Gab1 (Fig. 4 B).
The PH domain of Gab1 has been shown to be able to
bind phospholipids and is important for membrane tar-
geting (Isakoff et al., 1998; Maroun et al., 1999). How-
ever, deletion of the PH domain (
 
D
 
PH) did not reduce
the HGF/SF-induced association with Shp2, CRKL, or
PI(3)K (Fig. 4 B). CRKL binding was abrogated in the
Gab1 mutants expressing only the COOH terminus of
Gab1 (Gab1Cter) and strongly reduced in the mutant
lacking the CRKL-binding region (
 
D
 
CBR), while Shp2
can also associate with the COOH terminus of Gab1, but
requires Y628 which is mutated in Gab1
 
D
 
Shp2. As we
had observed by yeast two-hybrid analysis, the Gab1 mu-
tant 
 
D
 
PI(3)K which carries mutations in all three PI(3)K
consensus binding sites, can still associate with the p85
subunit of PI(3)K, even though less strongly than wild-
type Gab1 (Fig. 4 B). PI(3)K associates also efficiently
with Gab1Cter lacking amino acids 1–449, but this in-
teraction is strongly reduced by mutation of the re-
maining PI(3)K consensus binding sites, Y473 and Y590
(Cter
 
DPI(3)K) (Fig. 4 B).
Figure 4. Mapping the substrate-binding sites of Gab1. (A) Gab1
mutants were expressed as LexA-tpr-met fusion proteins and
tested for yeast two-hybrid interactions with substrates as in Fig.
3 A. CBR represents the CRKL-binding region of Gab1. Point
mutations were introduced into Gab1DPH or Gab1Cter se-
quence as indicated. Interactions were quantified by b-galacto-
sidase liquid assays and compared with the interaction of
Gab1DPH (set as 100). (B) Gab1 proteins and p85 PI(3)K were
expressed in 293 cells and following stimulation with HGF/SF,
examined for interactions with downstream interaction partners.
The Gab1 mutants are the same as in Fig. 4 A, except that the
DCBR, DPI(3)K, and DShp2 mutations were introduced into full-
size Gab1 cDNA. Gab1 proteins were precipitated with anti-Flag
beads and immune complexes detected by Western blotting.
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Gab1 Can Substitute for the Multiple Substrate Binding 
Domain of c-Met and Induce Branching Morphogenesis 
of MDCK Cells
c-Met associates with many signaling molecules including
Gab1 via the multiple docking site (Y14/Y15) at its COOH
terminus. This multiple docking site is essential for c-Met
function in vitro and in vivo (Ponzetto et al., 1994, 1996;
Fixman et al., 1995, 1996; Weidner et al., 1995; Maina et
al., 1996). Using chimeric receptors expressing the extra-
cellular domain of Trk and the intracellular domain of
c-Met or Trk plus the multiple docking site of c-Met, we
had determined that these docking sites are essential to
elicit a branching morphogenesis program in MDCK cells
(Weidner et al., 1995; Sachs et al., 1996). To test if Gab1 is
sufficient to mediate c-Met–specific signals, we substituted
the cytoplasmic tail of the trk-met construct with Gab1 se-
quences. When stimulated with NGF, the trk-met-Gab1
hybrid receptor, but not trk-met lacking the cytoplas-
mic tail, associates with CRKL, Shp2 and PI(3)K (Fig. 5
A). Trk-met-Gab1Cter expressing trk-met plus only the
COOH-terminal coding sequences of Gab1, residues
450–695, does not bind CRKL, but can still associate with
Shp2 and PI(3)K. The associations of Shp2 and PI(3)K de-
pend on Y628 or Y473 and Y590 which are mutated in trk-
met-CterDShp2 and trk-met-CterDPI(3)K, respectively
(Fig. 5 A). This suggests that Gab1 expressed in this hy-
brid form is efficiently phosphorylated and associates with
signaling molecules similar to Gab1 proteins stimulated by
activated c-Met.
To test for branching morphogenesis activity, we trans-
fected trk-met-Gab expression vectors into MDCK cells.
Stable cell clones expressing trk-met-Gab1 encoding just
the COOH terminus of Gab1 (trk-met-Gab1Cter) form
branching tubules in collagen matrix when stimulated with
NGF (Fig. 5 B). A trk-met construct lacking the c-Met
docking site sequences (trk-met-control) did not induce
branching tubuli. This suggests, that the COOH-terminal
region of Gab1, residues 450–695, can complement for the
function of the multiple docking site of c-Met. The COOH
terminus of Gab1 associates with PI(3)K and Shp2. To de-
termine if these interactions are essential for branching
morphogenesis, we tested trk-met-Gab1Cter constructs in
which PI(3)K-binding sites (DPI(3)K) or Shp2-binding
sites (DShp2) were mutated to phenylalanine. Trk-met-
CterDPI(3)K was still capable of inducing branching mor-
phogenesis of MDCK cells, while mutation of the Shp2-
binding site abolished this activity (Fig. 5 B). This suggests
that Shp2, but not PI(3)K-binding sites are essential for
branching morphogenesis activity.
It has been shown previously that PI(3)K as well as
MAPK pathways are required for branching morphogene-
sis activity (Khwaja et al., 1998): for instance, the PI(3)K
inhibitor LY294002 or the MEK kinase inhibitor PD98059
each blocked tubules formation of MDCK cells induced
by HGF/SF. Even though overexpression of constitu-
tively active p110 subunit of PI(3)K was sufficient to in-
duce branching tubules of MDCK cells, this activity was
blocked by MEK kinase inhibitors, suggesting that MAPK
is activated and also critical for this process.
Shp2 has been linked to activation of MAPK pathway
by several growth factors, like insulin, FGF, EGF, and IL3
and also activation of the Elk1 transcription factor, a sub-
Figure 5. Trk-met-Gab1 hy-
brids interact with down-
stream substrates and induce
branching morphogenesis of
MDCK cells. (A) Associa-
tion of trk-met-Gab1 fusion
proteins with signaling pro-
teins in 293 cells. After
stimulation with NGF, trk-
met-Gab1 proteins were pre-
cipitated using myc epitope-
tag. Coprecipitating proteins
were detected by immuno-
blotting. Trk-met-control en-
codes trk-met lacking the
multiple docking site of Met.
Gab1 proteins were fused
COOH-terminally of trk-
met. Gab1Cter encodes resi-
dues 450–695 of wild-type
Gab1, and CterDPI(3)K and
CterDShp2 express the
COOH-terminal coding se-
quences of the Gab1 mutants
DPI(3)K and DShp2 (as in
Fig. 4 A). (B) Association of
Gab1 with Shp2 is essential for c-Met–dependent branching morphogenesis activity. MDCK cells were stably transfected with the trk-
met-control and trk-met-Gab1Cter constructs as in A. Cell clones were seeded in collagen gel matrix and maintained in 10% FCS (a, d,
g, and j) or stimulated with NGF (b, e, h, and k) or HGF/SF (c, f, i, and l) for up to 7 d to induce tubulogenesis. Trk-met-GabCter, and
trk-met-CterDPI3K respond to NGF treatment (e and h), but not trk-met-CterDShp2 (k) in which the Shp2-binding site of Gab1 is mu-
tated.
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strate of MAPK and SAPK (Milarski and Saltiel, 1994;
Noguchi et al., 1994; Tang et al., 1995; Bennett et al., 1996;
Saxton et al., 1997; Gu et al., 1998; Hadari et al., 1998). To
test if Gab1-Shp2 association was involved in HGF/SF-
stimulated Elk1 transactivation, we carried out transient
reporter assays: 293 cells were cotransfected with expres-
sion plasmids for Gal4-Elk1 fusion protein and luciferase
reporter under control of a Gal4 promoter element (Gu et
al., 1998). Stimulation of the cells with HGF/SF results
in Elk1 phosphorylation and about 10-fold activation of
Gal4-Elk driven reporter gene (Fig. 6 A). Coexpression of
the Gab1 mutant DShp2 (Y628F), which lacks the Shp2-
Figure 6. Association of
Gab1 with Shp2 is required
for activation of the MAPK
pathway. (A) Elk1-depen-
dent reporter gene expression
is blocked by Gab1DShp2
mutant. 293 cells were tran-
siently transfected with 0.05
mg Gal4-Elk, 0.5 mg Gal4-
luciferase and 0.5 mg SV40
LacZ reporter plasmids plus
1 mg pBat-Flag (Control)
or Gab1 expression vectors.
Gab1 mutants are the same as
in Fig. 4 B. Cells were treated
with HGF/SF for 5 h and lu-
ciferase activity assessed from
normalized cell extract. Ali-
quots of the cell lysates were examined for Gab1 protein expression by Western blotting using Gab1 anti-serum (shown below). (B)
Catalytic inactive Shp2 mutants block HGF/SF-induced Elk1 activation. Luciferase reporter assays were carried out as in A. Cells were
cotransfected with empty vector (Control) or Shp2 expression vectors as indicated. Shp2DP carries a 31–amino acid internal deletion,
and Shp2CS a cysteine to serine point mutation at amino acid 453 in the phosphatase domain. In Shp2YF, tyrosine 542 and 580 are mu-
tated to phenylalanine (Bennett et al., 1996). Shown below, Shp2 protein expression of cell lysates. (C)  Gab1DShp2 attenuates HGF/SF-
stimulated phosphorylation of Erk2. 293 cells transfected with HA-tagged Erk2 and either pBat-Flag (Control) or Gab1 expression vec-
tors. After serum starvation, cells were stimulated with HGF/SF as indicated. HA-Erk2 was precipitated and phosphorylation detected
by immunoblotting with anti-active MAPK antiserum (pErk). Below: Gab1 protein expression was examined from the total cell lysates
(lane C represents control lysate from unstimulated cells).
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binding site, strongly reduced HGF/SF-dependent transac-
tivation of Elk1. Expression of Gab1 proteins was evalu-
ated by Western blotting of the cell lysates (Fig. 6 A).
Wild-type Gab1 or Gab1 mutant DPI(3)K were expressed
at levels comparable to GabDShp2, but did not have a sig-
nificant effect on basal or HGF/SF-stimulated Elk1 trans-
activation. Overexpression of catalytically inactive Shp2
mutants Shp2DP or Shp2CS attenuated Elk1-dependent
reporter gene activity (Fig. 6 B). We also monitored the
activation status of the MAPK Erk2 in response to HGF/
SF by Western blotting using antibodies that recognize
specifically the phorphorylated form of Erk2 (Fig. 6 C).
Phosphorylation of Erk2 was strongest after 10 min of
HGF/SF stimulation and reduced by overexpression of the
Gab1 mutant DShp2. It is assumed that the transfected
Gab1 mutant proteins compete with endogenous Gab1 as
well as other c-Met substrates for binding to the multiple
docking site of activated c-Met receptor. Without the
Shp2-binding site, Gab1 is unable to transmit the c-Met–
induced MAPK phosphorylation and Elk1 activation, im-
plicating Shp2 in the transduction of Gab1-dependent sig-
nals.
Discussion
Gab1 is a specific intracellular substrate of the receptor ty-
rosine kinase c-Met and involved in c-Met–specific signal-
ing pathways induced by HGF/SF. In this work, we ana-
lyzed the interaction of Gab1 with the c-Met receptor and
examined its association with downstream targets induced
by Gab1 phosphorylation. Interaction with c-Met is medi-
ated via a unique phosphotyrosyl interaction site, the 13–
amino acid c-Met–binding site MBS. Upon stimulation
with HGF/SF, Gab1 is phosphorylated by c-Met and asso-
ciates with the signaling molecules PI(3)K, Shp2, PLC-g,
Shc (Holgado-Madruga et al., 1996; Ingham et al., 1998;
Takahashi-Tezuka et al., 1998; Maroun et al., 1999), and
the newly identified interaction partner, CRKL. By using
a trk-met-Gab1 hybrid, we found that association of Gab1
with Shp2, but not PI(3)K or CRKL is essential for c-Met-
Gab1–induced branching morphogenesis activity. This is
direct evidence that Gab1 is sufficient to mediate c-Met
specific signals in cultured cells. A fundamental role of
Gab1 for c-Met–specific signaling is supported by re-
cent gene ablation experiments in the mouse: Gab12/2
embryos display reduced liver size, placental defects and
are characterized by strongly reduced and delayed migra-
tion of myogenic precursor cells into the limbs (Sachs, M.,
H. Brohmann, D. Zechner, T. Müller, J. Hülsken, U.
Schaeper, C. Birchmeier, and W. Birchmeier, manuscript
submitted for publication), a phenotype reminiscent of
HGF/SF2/2and c-Met2/2 mutant embryos (Bladt et al.,
1995).
The c-Met–binding site of Gab1 was identified geneti-
cally by reverse yeast two-hybrid technology (Vidal et al.,
1996a): by using a double selection protocol to screen
Gab1 mutants against c-Met association, but for Grb2
binding, we enriched for mutations that interfered with
c-Met association, but not with other protein functions. The
positions of single point mutations that reduce c-Met asso-
ciation define the MBS, residues 487–499 of Gab1. Most
likely, the MBS is the site of direct contact with c-Met,
since insertion of the MBS confers c-Met–binding activity
to p97/Gab2. Additional residues within the MBD or the
homologous region of p97/Gab2 are also required to form
a functional c-Met–binding site, since the minimal domain
sufficient for c-Met interaction is larger, 450–532 of Gab1,
and peptides corresponding to MBS sequence did not
block c-Met association (Weidner et al., 1996, and data not
shown).
By a similar screening protocol, we were able to locate a
Grb2-binding site in the Gab1 sequence PPVDRNLKP,
residue 518–526, which does not conform to the common
proline-rich consensus binding motif for SH3 domains,
PXXP (Feng et al., 1994). It is also distinct from the re-
cently discovered SH3-binding motif, PXXDY, found in
Eps8 interacting peptides (Mongiovi et al., 1999). Similar
sequences are present in the Grb2-binding docking pro-
teins p97/Gab2, SLP-76, and BLNK and in Drosophila
DOS (Gu et al., 1998; Jackman et al., 1995; Motto et al.,
1996; Fu et al., 1998; Raabe et al., 1996), but until now,
they have not been recognized as putative Grb2 consensus
binding sites.
While the MBS of Gab1 mediates the direct contact
with c-Met, Grb2 has also been implicated in mediating
indirectly the association of Gab1 with c-Met. Mutation
of the Grb2 consensus binding site of c-Met, Y1356VNV
to Y1356VHV, reduced interaction with Gab1 in cells
(Bardelli et al., 1997; Nguyen et al., 1997). But since this
mutation is in the multiple docking site of c-Met, it was not
clear if interactions with other as yet unidentified adaptor
proteins or the direct interaction with Gab1 itself were dis-
turbed. We could now address this question by expressing
Gab1 mutants deficient for direct association with c-Met
or Grb2. We showed that Gab1 mutants deficient in Grb2
binding associate with c-Met, even though with reduced
strength compared with wild-type Gab1. This demon-
strates that in cells, association with c-Met is direct and re-
quires the MBS. This is consistent with our finding that
p97/Gab2, which binds Grb2 but not c-Met, associates
with c-Met when the c-Met–binding site of Gab1 is in-
serted. Gab1 was originally cloned as a Grb2 interact-
ing protein and interacts strongly with Grb2 (Holgado-
Madruga et al., 1996, and this paper). We identified two
Grb2-binding sites present in the Gab1 sequence. The first
site is located at residues 341–348 and conforms to the
classical proline-rich consensus binding motif PXXP for
SH3 domains (Feng et al., 1994). The second binding site is
located in close proximity to the MBS and constitutes a
novel Grb2-binding motif PX(V/I)(D/N)RXXKP. Both
sites can mediate Grb2 association and are conserved in
the Gab1-related protein p97/Gab2. Since Gab1 binds the
SH3 domains of Grb2, the SH2 domain of Grb2 can con-
tribute to the cellular association of Gab1 with c-Met (Fig.
7), but could also couple Gab1 to other signaling path-
ways. For instance, Gab1 is also a substrate of the EGF re-
ceptor, the insulin receptor, and the NGF receptor trk
(Holgado-Madruga et al., 1996, 1997). The EGF receptor
binds Grb2 directly, and its Grb2-binding sites are also re-
quired for recruitment of Gab1 (Okutani et al., 1994; Rod-
rigues et al., 2000); thus, the EGF receptor may recruit
Gab1 via Grb2-Gab1 complexes. Trk and insulin receptors
could couple to Gab1 by association with the Shc adap-
tor, which upon phosphorylation binds Grb2 complexes
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(Skolnik et al., 1993; Dikic et al., 1995). Similarly, Gab1 is
phosphorylated in response to cytokines and involved in
activation of the MAPK pathway (Takahashi-Tezuka et
al., 1998). This activation requires the Shp2-binding site of
the cytokine receptor gp130 and correlates with associa-
tion of Gab1 with Shp2 and PI(3)K. While Gab1 does not
interact directly with gp130 (Takahashi-Tezuka et al.,
1998), it could be recruited indirectly via association with
Grb2 and phosphorylated Shp2.
To characterize the interaction of Gab1 with down-
stream substrates, we have modified the classical yeast
two-hybrid assay (Chien et al., 1991). Fusion of Gab1 with
the constitutively active kinase, tpr-met oncogene, in-
duces tyrosine phosphorylation and interaction with sig-
naling molecules like PI(3)K, PLC-g, and Shp2. The ad-
vantage of this system over the tribrid approach (Licitra
and Liu, 1996; Rocchi et al., 1998) is that it can be easily
adapted to the two-hybrid system available and does not
require a third genetic marker for expression of tpr-met
kinase. In addition, we observed that the kinase tpr-met is
less toxic in yeast when expressed as a bait with the LexA
DNA-binding domain than in its cytoplasmic form. By
yeast two-hybrid screening, we identified CRKL as a new
interaction partner for Gab1. CRKL is a Crk-related
adaptor protein that consists of one SH2 and two SH3 do-
mains (ten Hoeve et al., 1993). The interaction of CRKL
with Gab1 is mediated via its SH2 domain, and the
CRKL-binding site of Gab1 maps to amino acids 242–410.
Interestingly, this region contains a cluster of 6 Crk/
CRKL consensus binding sites (YXXP; Songyang et al.,
1993). Multiple Crk/CRKL-binding sites are also clus-
tered in the substrate binding regions of the Crk/CRKL
interacting docking protein p130Cas and the Cas-like
docking proteins CasL/HEF1 and Efs/Sinthe (Sakai et al.,
1994; Ishino et al., 1995; Astier et al., 1997), suggesting a
common theme in which multiple CRKL complexes could
be recruited simultaneously. Via its SH3 domains, CRKL
can associate with multiple effector proteins, like C3G (a
GDP GTP exchange factor for Rap1), the tyrosine kinase
c-Abl, HPK (human progenitor kinase), and p85 PI(3)K
subunit (reviewed by Feller et al., 1998). Crk and CRKL
have been implicated in the activation of JNK and Rap1
kinase pathways (Gotoh et al., 1995; Tanaka and Ha-
nafusa, 1998). Recently, it was shown that HGF/SF stimu-
lates Rap1 activation that is dependent on C3G and
Gab1-CRKL association (Sakkab et al., 2000). Since
c-Met does not bind CRKL directly, recruitment of
CRKL-C3G complexes by Gab1 is the likely mechanism
that leads to Rap1 activation. The interaction of CRKL
with p85 PI(3)K could explain the significant association
of p85 with Gab1 mutants where all three PI(3)K consen-
sus binding sites are mutated. Future experiments will de-
termine which CRKL-dependent pathways are important
for Gab1 function in cells.
The activity of Gab1 mutants was examined in c-Met–
dependent branching morphogenesis assays. Trk-met hy-
brid receptors have been useful for the analysis of mutant
receptor function, since they can be activated in the
absence of endogenous wild-type receptor stimulation
(Weidner et al., 1993; Sachs et al., 1996). We carried this
analysis further and tested the activity of the kinase sub-
strate Gab1 by fusing it to the COOH terminus of trk-met.
This hybrid receptor approach allowed us to control the
activity of exogenous Gab1 by stimulation with NGF, this
is in contrast to the overexpression of Gab1, which may re-
sult in constitutive activation (Weidner et al., 1996). A trk-
met-Gab1 hybrid receptor expressing just the COOH ter-
minus of Gab1, residues 450–695, was sufficient to induce
branching morphogenesis activity in response to NGF ac-
tivation. Importantly, we found that association of Gab1
with Shp2 is essential for Gab1-induced branching mor-
phogenesis, since a mutation in the Shp2-binding site abro-
gated this activity (Fig. 5 B). Shp2 has previously been
shown to be involved in many morphological processes:
for instance FGF- or activin-dependent mesoderm induc-
tion, cell spreading, and migration (Tang et al., 1995; Yu et
al., 1998; Saxton and Pawson, 1999). As a consequence,
Shp22/2 mice display severe defects in mesodermal pat-
terning and gastrulation (Saxton et al., 1997). Genetic evi-
dence has linked Corkscrew, the Drosophila homologue of
SHP2, to DOS, a Gab1-like docking protein, and to activa-
tion of the MAPK pathway (Herbst et al., 1996; Raabe et
al., 1996). We could show that association of Gab1 with
Shp2 is also required for HGF/SF-dependent Erk2 phos-
phorylation and Elk1 activation, a substrate of MAPKs.
The mechanism by which Shp2 transduces c-Met/Gab1–
specific signals is not known. Shp2 is a tyrosine phos-
phatase, and via its catalytic activity could modulate the
activity of other enzymes regulating the MAPK cascade.
Its phosphatase activity has been shown to be essential for
mesoderm induction and for activation of the MAPK
Figure 7. Scheme of Gab1 associations. Gab1 binds to the bi-
partide docking site (Y14, Y1349 and Y15, Y1356) of activated
c-Met receptor. Direct association of Gab1 to c-Met requires the
c-Met–binding site (MBS) of Gab1, while the interaction with
Grb2 is constitutive and mediated via the Grb2-binding sites
(GBS). The MBS is essential for the cellular association of Gab1
with c-Met, but the Grb2-binding sites also contribute to the
strength of the interaction. Grb2 binds Y15 of c-Met via SH2 do-
main and Gab1 via SH3 domains, thereby stabilizing Gab1-c-Met
associations in vivo. Upon phosphorylation, Gab1 associates with
PI(3)K, CRKL and Shp2. Recruitment of Shp2 is essential for
MAPK activation and c-Met/Gab1–dependent morphogenesis.
(PP) indicates poly proline SH3 interaction site.
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pathway by a number of growth factors, like EGF, FGF
and IL3 (Bennett et al., 1996; O’Reilly and Neel, 1998; Gu
et al., 1998). In addition, Shp2 could function as an adap-
tor: upon phosphorylation it can bind the SH2 domain of
Grb2 and by targeting Grb2/Sos complexes to the mem-
brane, could directly activate the Ras pathway (Li et al.,
1994; Bennett et al., 1994). We observed that catalytic in-
active Shp2 mutants block HGF/SF-dependent Elk activa-
tion, suggesting that the phosphatase activity of Shp2 is
critical for Gab1/Shp2 signaling. A 90-kD protein that can
serve as a substrate of Shp2 has recently been identified in
a complex with Gab1 and thus could play a role in this
pathway (Shi et al., 2000).
Surprisingly, direct association with PI(3)K does not ap-
pear not to be essential for branching morphogenesis ac-
tivity induced by the trk-met-Gab1 hybrid, even though it
was shown by the use of chemical inhibitors LY294002 and
PD98059 that PI(3)K as well as MAPK activity are re-
quired for this process (Khwaja et al., 1998). This could be
due to high basal PI(3)K activity observed in unstimulated
MDCK cells (Maroun et al., 1999) or residual PI(3)K acti-
vation by the Gab1DPI(3)K mutant. It was also shown that
overexpression of Gab1 mutants lacking PI(3)K-binding
sites could partially rescue branching morphogenesis de-
fects of c-Met receptor mutants with reduced affinity for
Gab1 (Maroun et al., 1999), indicating that further activa-
tion of PI(3)K by Gab1 is not required for branching mor-
phogenesis. Using the same assay, it was shown that the
PH domain of Gab1 is required for branching morphogen-
esis and membrane targeting (Maroun et al., 1999). How-
ever, the PH domain is not essential for branching mor-
phogenesis activity induced by the trk-Met-Gab1 fusion
protein, suggesting that its primary function is to target
Gab1 to the cell membrane, an activity redundant for the
transmembrane fusion protein trk-met-Gab1.
A growing number of docking proteins has been identi-
fied that is involved in the activation of specific signaling
pathways of tyrosine kinases. They differ by their ability to
couple to respective tyrosine kinase receptors, by expres-
sion pattern, but also by association with different sets of
effector molecules. For instance, IRS-1 interacts with
PI(3)K, Grb2, Shc, Shp2, Csr, Nck, and Fyn (reviewed by
Ogawa et al., 1998). Studies using biochemical inhibitors
for PI(3)K activity have shown that the PI(3)K pathway
plays a fundamental role for metabolic changes induced by
insulin. The PI(3)K pathway is also critical for insulin
receptor/insulin-like growth factor receptor signaling in
Drosophila and C. elegans, since many genes that affect
the pathways encode proteins that are involved in the
PI(3)K cascade, like p110 PI(3)K itself, p110 substrates
Akt1, Akt2 and Daf-16, a potential substrate of Akt ki-
nase pathways and PTEN (Morris et al., 1996; Kimura et
al., 1997; Ogg and Ruvkun, 1998; Paradis and Ruvkun,
1998; Staveley et al., 1998). In contrast, p62dok family
members have been shown to associate with p120RasGAP,
Nck and Crk family members (Carpino et al., 1997; Yama-
nashi and Baltimore, 1997; Bhat et al., 1998; Di Cristofano
et al., 1998; Jones and Dumont, 1998; Nelms et al., 1998).
A p62dok mutant impaired for binding to Nck and
p120RasGAP is unable to promote insulin-stimulated cell
migration, implicating Nck and/or p120RasGAP as impor-
tant effectors for p62dok signaling (Noguchi et al., 1999).
The Gab1 family proteins Gab1 and p97/Gab2 associate
with PI(3)K, PLC-g, Shc, and Shp2 (Holgado-Madruga et
al., 1996; Gu et al., 1998; Takahashi-Tezuka et al., 1998;
Lecoq-Lafon et al., 1999; Nishida et al., 1999). In addition,
we could demonstrate association of Gab1 with CRKL.
The binding sites for PI(3)K, Shp2, and CRKL, as well as
SH3-binding sites for Grb2 are conserved in p97/Gab2 and
Drosophila DOS, suggesting that Gab1 family members
function by activating a similar set of signal transducers.
Shp2 has been linked to DOS as a modulator in Sevenless
receptor signaling, and p97/Gab2 requires association with
Shp2 for gene regulation (Herbst et al., 1996; Raabe et al.,
1996; Gu et al., 1998). In this paper, we could show that
Shp2 is an important effector for Gab1 signaling, suggest-
ing that Shp2 is critical for the function of Gab1 family
members.
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